切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2009, Vol. 05 ›› Issue (05) : 473 -476. doi: 10.3877/cma.j.issn.1673-5250.2009.05.104

论著

华蟾素对子宫内膜癌HHUA细胞芳香化酶表达的影响和意义
王绍光, 姜学强   
  1. 264000 山东青岛,青岛大学医学院附属烟台毓璜顶医院妇产科
  • 出版日期:2009-10-01

Effects and Significance of Cinobufagin on the Expression of Aromatase in the Endometrial Carcinoma HHUA Cells

Shao-guang WANG, Xue-qiang JIANG   

  1. Department of Obstetrics and Gynecology, Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai 264000, China
  • Published:2009-10-01
  • Supported by:
    * Project No. 2005126, supported by the Yantai Science and Technology Development Plan
引用本文:

王绍光, 姜学强. 华蟾素对子宫内膜癌HHUA细胞芳香化酶表达的影响和意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2009, 05(05): 473-476.

Shao-guang WANG, Xue-qiang JIANG. Effects and Significance of Cinobufagin on the Expression of Aromatase in the Endometrial Carcinoma HHUA Cells[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2009, 05(05): 473-476.

目的

探讨华蟾素(cinobufagin)对体外培养子宫内膜癌HHUA细胞芳香化酶和雌二醇(estradiol,E2)表达的影响和意义。

方法

30例原代培养的正常子宫内膜组织和30例子宫内膜癌HHUA细胞分别取自2007年至2008年因功能性子宫出血(功血)而在本院诊刮和因子宫内膜癌在本院手术治疗患者。其组织学检查分别确诊为增生期内膜和子宫内膜癌HHUA细胞,体外(in vitro)培养正常子宫内膜细胞(A组,n=30)和子宫内膜癌HHUA细胞。再将30例子宫内膜癌患者的子宫内膜癌HHUA细胞分成两部分,一部分纳入子宫内膜癌HHUA细胞组(B组,n=30),一部分用华蟾素干预后,纳入子宫内膜癌HHUA细胞华蟾素干预组(C组,n=30),应用RT–PCR检测芳香化酶表达,发光免疫法检测雌二醇表达,流式细胞仪检测细胞凋亡。

结果

正常子宫内膜细胞(A组)不表达芳香化酶mRNA(aromatase mRNA),不合成雌二醇,细胞凋亡率为(8.02±0.93)%;子宫内膜癌HHUA细胞(B组)表达芳香化酶mRNA,可合成雌二醇,细胞凋亡率为(1.08±0.21)%,低于正常子宫内膜细胞 (P<0.05)。华蟾素干预(C组)后,子宫内膜癌HHUA细胞芳香化酶mRNA的表达和雌二醇的合成均下降,细胞凋亡率为(27.14±4.12)%,高于B组(P<0.05)。

结论

子宫内膜癌HHUA细胞可利用芳香化酶合成内源性雌二醇,华蟾素可抑制子宫内膜癌HHUA细胞芳香化酶mRNA的表达和雌二醇的合成,抑制癌细胞增殖。

Objective

To investigate the effects and significance of cinobufagin on the expression of aromatase and estrodiol(E2) in the endometrial carcinoma HHUA cells cultured in vitro.

Methods

The primary culture of normal endometrial cells were taken from patients who did diagnostic curettage for functional uterine bleeding(FUB) in our hospital from 2007 to 2008, and the pathology revealed proliferative endometrial cells as the normal endometrial cells(group A, n=30). The pathology revealed as the endometrial carcinoma HHUA cells which were divided into two parts. Half of them were classified into endometrial carcinoma HHUA cells group (group B, n=30), and half were cultured in vitro, after the action of cinobufagin into endometrial carcinoma HHUA cells action by cinobufagin group (group C, n=30). The expression of aromatase was measured by RT-PCR, the expression of estrodiol was determined by immunofluorometry, and the cellular apoptosis was tested by flow cytometry.

Results

Group A neither expressed aromatase mRNA nor synthesize estrodiol, the cellular apoptotic rate was (8.02±0.93)%. Group B could both express aromatase mRNA and synthesize estradiol by the aromatase, and the cellular apoptotic rate was (1.08±0.21)%, which was lower than that of group A(P<0.05). After the action of cinobufagin(group C), aromatase mRNA expression and estrodiol synthesis of endometrial carcinoma HHUA cells were significantly down-regulated, the cellular apoptotic rate was (27.14±4.12)%, which was lower than that of group B (P<0.05).

Conclusion

The endometrial carcinoma HHUA cells can synthesize endogenous estradiol by aromatase. The cinobufagin may inhibit the expression of aromatase mRNA and the synthesis of the estrodiol, resulting the inhibition of endometrial carcinoma cells' proliferation.

图1 子宫内膜癌HHUA细胞芳香化酶mRNA电泳光带
1 Krasner C. Aromatase inhibitors in gynecologic cancers. J Steroid Biochem Mol Biol, 2007, 106(1–5): 76–80.
2 Bulun SE, Chen D, Lu M, et al. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol, 2007, 106(1– 5): 81–96.
3 Gurates B, Sebstian S, Yang S, et al. WT1 and DAX–1inhibit aromatase p450 expression in human endometrial and endometriotic stromal cell. J Clin Endocrinol Metab, 2007, 87(9): 4369–4367.
4 Gligorov J, Pritchard K, Goss P. Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis. Breast, 2007, 16(3): 1–9.
5 Utsunomiya H, Yaegashi N. Biological roles of estrogen and progesterone in human endometrial carcinoma–new developments in potential endocrine therapy for endometrial cancer. Endocr J, 2007, 54(5): 667–679.
6 Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE review. Am J Epidemiol, 2007, 165(3): 235–245.
7 Khadzhiolov N, Ivanov S. Expression of oncogene proteins Bag–1, p53, and bcl–2 in endometrium adenocarcinoma with different rate of differentiation. Akush Ginekol, 2004, 43(2): 35–36.
[1] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[2] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[3] 孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[4] 廖泽楷, 梁爱琳, 龚启梅. 根尖周病中程序性细胞死亡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 150-155.
[5] 唐亦骁, 陈峻, 连正星, 胡海涛, 鲁迪, 徐骁, 卫强. 白果内酯对小鼠肝缺血再灌注损伤保护作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 278-282.
[6] 胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[7] 郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[8] 李勇, 彭天明, 王倩倩, 陈育纯, 蒲小勇, 刘久敏. 基于失巢凋亡相关基因的膀胱癌预后模型构建及分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 331-339.
[9] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[10] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[11] 刘杜先, 张杰东, 付鲁渝, 熊志强, 龚程, 张小雅, 高明悦, 孟俊宏, 刘兰侠. 沉默circXPO1抑制肝癌细胞恶性生物学行为[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 159-166.
[12] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[13] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[14] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[15] 刘霖, 张文欢, 宋雅茹, 姜云璐. Apelin-13 在阿尔茨海默病中的神经保护作用机制研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 276-280.
阅读次数
全文


摘要